279. Inhaled Sargramostim (rhu GM-CSF) Leads to Enhanced SARS-CoV-2 Virus-Specific Immune Response and Viral Clearance: Results of the Biomarker Cohort of a Randomized, Double-Blind, Placebo-Controlled Phase 2b Trial in Non-Hospitalized Patients with COVID-19
Ila Joshi, Fiona Garner, Debasish F Roychowdhury, Lorinda Simms, Sanjeev Ahuja, John L McManus, Edwin P Rock, Rodolfo Perez, Sandro Bacchelli, Robert Paine
Pharmacology, Toxicology and Pharmaceutical Science
1
100%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 526. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2023.
All research outputs
#46,219
of 25,046,311 outputs
Outputs from Open Forum Infectious Diseases
#25
of 4,488 outputs
Outputs of similar age
#585
of 259,669 outputs
Outputs of similar age from Open Forum Infectious Diseases
#1
of 184 outputs
Altmetric has tracked 25,046,311 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,488 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,669 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 184 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.
